Quantitative Imaging in Cancer Evolution and Ecology

Количественная визуализация в эволюции и экологии рака
Robert J. Gillies, Robert A. Gatenby, Olya Grove
2013-09-23

cancer evolutionintratumoral habitatsquantitative imagingradiologic heterogeneitytumor heterogeneity
Cancer therapy, even when highly targeted, typically fails because of the remarkable capacity of malignant cells to evolve effective adaptations. These evolutionary dynamics are both a cause and a consequence of cancer system heterogeneity at many scales, ranging from genetic properties of individual cells to large-scale imaging features. Tumors of the same organ and cell type can have remarkably diverse appearances in different patients. Furthermore, even within a single tumor, marked variations in imaging features, such as necrosis or contrast enhancement, are common. Similar spatial variations recently have been reported in genetic profiles. Radiologic heterogeneity within tumors is usually governed by variations in blood flow, whereas genetic heterogeneity is typically ascribed to random mutations. However, evolution within tumors, as in all living systems, is subject to Darwinian principles; thus, it is governed by predictable and reproducible interactions between environmental selection forces and cell phenotype (not genotype). This link between regional variations in environmental properties and cellular adaptive strategies may permit clinical imaging to be used to assess and monitor intratumoral evolution in individual patients. This approach is enabled by new methods that extract, report, and analyze quantitative, reproducible, and mineable clinical imaging data. However, most current quantitative metrics lack spatialness, expressing quantitative radiologic features as a single value for a region of interest encompassing the whole tumor. In contrast, spatially explicit image analysis recognizes that tumors are heterogeneous but not well mixed and defines regionally distinct habitats, some of which appear to harbor tumor populations that are more aggressive and less treatable than others. By identifying regional variations in key environmental selection forces and evidence of cellular adaptation, clinical imaging can enable us to define intratumoral Darwinian dynamics before and during therapy. Advances in image analysis will place clinical imaging in an increasingly central role in the development of evolution-based patient-specific cancer therapy.
1
Cancer therapy commonly fails because malignant cells evolve effective adaptations under heterogeneous environmental selection pressures.
2
Intratumoral evolution is governed by reproducible interactions between environmental selection forces and cellular phenotype, rather than by random mutations alone.
3
Quantitative clinical imaging can potentially assess and monitor intratumoral evolution by linking regional environmental properties with cellular adaptive strategies.
4
Spatially explicit imaging identifies distinct intratumoral habitats, including regions that may contain more aggressive and less treatable tumor populations than others.
5
Tumor heterogeneity occurs across genetic, cellular, and imaging scales, including substantial spatial variation in necrosis, contrast enhancement, and genetic profiles within individual tumors.

intratumoral cancer heterogeneity and evolution

spatially resolved relationships between tumor microenvironmental selection forces and cellular adaptive strategies, assessed through quantitative clinical imaging

Publication Details
Publication Date
2013-09-23
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Robert J. Gillies
Robert A. Gatenby
Olya Grove
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%